Pfizer and the Wellcome Trust have launched a multi-year, public-private research collaboration with the governments of four African countries aimed at supporting the implementation of national action plans for antimicrobial resistance in the countries concerned – Ghana, Kenya, Malawi, and Uganda.
The “Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance” (SPIDAAR) has been developed to track resistance patterns and...





